California Independent Bancorp (CIB) has dismissed at least one offer, and with the help of a share buyback and a poison pill, seems to be very keen on keeping its independence. A Nov. 29 release revealed $55 million market cap CIB took a defensive posture following a $67 million bid from Ronald Bachli, of San Francisco-based Belvedere Capital Partners LLC.
To read the entire story, you must be logged in.
Please log in now or register with us.
